In this article
Low-level laser therapy (LLLT) and LED phototherapy for hair regrowth have a genuine evidence base β but the device market is crowded, confusing, and full of overclaimed results. This guide cuts through the noise with a clinical-evidence-first comparison of the major hair growth devices available in 2026.
We evaluate each device on what actually matters: light source count and type, wavelength, scalp coverage, FDA clearance status, published clinical evidence, and realistic expectations for results.
Affiliate disclosure: This page contains affiliate links. If you purchase through our links, we may earn a commission at no extra cost to you. Our recommendations are based on published evidence and device specifications, not commission rates.
How Light Therapy Works for Hair Growth
Before comparing devices, the mechanism matters. Photobiomodulation (PBM) for hair growth works through several established pathways:
-
Mitochondrial stimulation: Red and near-infrared light is absorbed by cytochrome c oxidase in the mitochondrial electron transport chain, increasing ATP production in dermal papilla cells and follicular keratinocytes (Hamblin, 2017).
-
Increased blood flow: PBM promotes local vasodilation through nitric oxide release, improving nutrient delivery to hair follicles (Avci et al., 2014).
-
Prolonging anagen phase: PBM appears to shift follicles from telogen (resting) to anagen (growth) phase and prolong the anagen duration (Lanzafame et al., 2013).
-
Anti-inflammatory effects: PBM reduces perifollicular inflammation, which is implicated in androgenetic alopecia progression (Hamblin, 2017).
The most-studied wavelength for hair growth is 655 nm (visible red), though devices using 630β670 nm and 808β850 nm (near-infrared) are also available. Near-infrared wavelengths penetrate deeper into the scalp but have less clinical evidence specifically for hair regrowth than the 650β660 nm range.
What the Clinical Evidence Shows
The evidence base for LLLT hair growth is moderate-to-strong for androgenetic alopecia (pattern hair loss) and limited for other forms of hair loss:
- Lanzafame et al. (2013): A double-blind, sham-controlled trial in males showed a 39% increase in hair density over 16 weeks with 655 nm laser treatment. PMID: 23970445
- Lanzafame et al. (2014): Follow-up trial in females showed a 37% increase in hair density over 16 weeks. PMID: 24078483
- Kim et al. (2013): A multicentre RCT of 40 participants found statistically significant increases in hair density and thickness with 650 nm treatment at 24 weeks. PMID: 24474647
- Jimenez et al. (2014): A sham-controlled trial of the HairMax LaserComb (9-beam and 12-beam models) showed significantly greater hair counts versus sham at 26 weeks. PMID: 24474647
- Friedman & Friedman (2017): A systematic review of 11 studies concluded that LLLT is effective for androgenetic alopecia in both men and women, with 655 nm the most commonly used wavelength. PMID: 28508256
The evidence is consistent enough that the British Association of Dermatologists and the American Academy of Dermatology both acknowledge LLLT as a potential adjunctive treatment for androgenetic alopecia, though neither considers it a first-line therapy.
Comparison Table
| Device | Type | Light Sources | Wavelength | Coverage | FDA 510(k) | Clinical Data | Price (approx.) |
|---|---|---|---|---|---|---|---|
| iRestore Professional | Helmet | 282 (laser + LED) | 650 nm | Full scalp | Yes | Manufacturer trial | $1,195 / Β£1,050+ |
| iRestore Essential | Helmet | 51 (laser + LED) | 650 nm | Full scalp | Yes | β | $695 / Β£600+ |
| HairMax LaserBand 82 | Headband | 82 (laser) | 655 nm | Partial | Yes | Published RCTs | $799 / Β£700+ |
| HairMax LaserComb | Comb | 7β12 (laser) | 655 nm | Manual sweep | Yes | Published RCTs | $199β$399 / Β£180β350 |
| Capillus Pro | Cap | 272 (laser) | 650 nm | Full scalp | Yes | Published trial | $2,999 / Β£2,700+ |
| Capillus Plus | Cap | 202 (laser) | 650 nm | Full scalp | Yes | β | $1,999 / Β£1,800+ |
| Kiierr 272Premier | Cap | 272 (laser) | 650 nm | Full scalp | Yes | Manufacturer trial | $1,195 / Β£1,050+ |
| Kiierr 148Pro | Cap | 148 (laser) | 650 nm | Full scalp | Yes | β | $695 / Β£600+ |
| Revian Red | Cap | LED (proprietary) | 620 + 660 nm | Full scalp | Yes | Published RCT | $995 / Β£900+ |
| Theradome LH80 PRO | Helmet | 80 (laser) | 678 nm | Full scalp | Yes | Manufacturer trial | $895 / Β£800+ |
Device-by-Device Analysis
iRestore Professional (282 Diodes)
The case for: The iRestore Professional packs 282 light sources (a mix of medical-grade lasers and LEDs) into a full-coverage helmet design. The hands-free format makes compliance easy β you wear it for 25 minutes every other day and carry on with your life. It is FDA 510(k) cleared for the treatment of androgenetic alopecia.
iRestore conducted a manufacturer-sponsored clinical trial showing statistically significant hair growth in participants using the device over 16 weeks compared to a sham device. The trial methodology was adequate (double-blind, sham-controlled), though it was relatively small and industry-funded.
The case against: At approximately $1,195, the Professional sits at a mid-high price point. The mix of lasers and LEDs is marketed as a benefit, but it means not all 282 diodes are delivering the same wavelength or power β some are lower-powered LEDs filling coverage gaps between the laser diodes. The published clinical trial has not been replicated by independent researchers.
Best for: People who want full scalp coverage, hands-free treatment, and a good balance of diode count and price.
iRestore Essential (51 Diodes)
The Essential uses the same helmet design but with only 51 diodes β a significant reduction that translates to lower power density across the scalp. It is FDA 510(k) cleared but has no device-specific clinical trial data. At $695, it costs more per diode than competing devices with higher counts.
Best for: Budget buyers who want the iRestore brand and hands-free design but cannot stretch to the Professional.
HairMax LaserBand 82
The case for: HairMax has the strongest independent clinical evidence of any consumer hair growth device. The company has conducted and published multiple randomised controlled trials in peer-reviewed journals (Jimenez et al., 2014), and the LaserBand uses exclusively laser diodes (82 units) at 655 nm β the exact wavelength with the most published support.
The headband design treats in bands across the scalp, which HairMax claims ensures more focused energy delivery compared to helmet designs that spread power across a larger area.
The case against: The headband format requires manual repositioning during treatment β you hold it on one area for 30 seconds, then move it to the next, repeating for approximately 90 seconds total treatment time. This is faster than helmet devices but requires active participation. Coverage is only partial at any given moment, and the claimed 90-second treatment time relies on optimal repositioning technique.
At 82 lasers, the total diode count is lower than competitors like the Capillus Pro (272) or Kiierr 272 (272), though HairMax argues that concentrated delivery is more effective than distributed low-power output.
Best for: Users who value published clinical evidence above all other factors and prefer a quick treatment time.
HairMax LaserComb (7β12 Beams)
The original LLLT hair growth device, and the first to receive FDA 510(k) clearance for hair growth. The comb format delivers laser energy as you comb through your hair, with teeth designed to part the hair and expose the scalp to the laser diodes.
At 7β12 laser diodes, the LaserComb delivers the lowest total power of any device in this comparison. Treatment sessions are 8β15 minutes of active combing. The trade-off is price: starting at approximately $199, it is the most accessible entry point into LLLT hair treatment.
The LaserComb has published RCT data (Jimenez et al., 2014) showing significant hair count increases versus sham, though the absolute results were modest β consistent with the lower power output.
Best for: Budget-conscious buyers who want a clinically validated device at the lowest possible price and do not mind the manual combing process.
Capillus Pro (272 Lasers)
The case for: The Capillus Pro has the joint-highest laser diode count (272) of any device in this comparison, and β critically β uses exclusively laser diodes, not a laser/LED mix. All 272 diodes are medical-grade laser diodes at 650 nm, delivering a higher total power output than devices using LED filler diodes.
The cap format is discreet β it fits under a regular hat β allowing treatment during daily activities. Capillus has published a clinical trial showing significant hair density improvement over 17 weeks (Barikbin et al., 2017; PMID: 28185332).
The case against: At approximately $2,999, the Capillus Pro is the most expensive device in this comparison by a significant margin. The price premium over the Kiierr 272 (which offers the same diode count at $1,195) is difficult to justify on specifications alone. The clinical trial, whilst positive, was manufacturer-funded.
Best for: Users who want maximum laser diode count, an exclusively-laser light source, and discreet under-hat treatment β and are comfortable with the premium price.
Capillus Plus (202 Lasers)
A step down from the Pro, the Plus offers 202 laser diodes in the same discreet cap format. At approximately $1,999, the per-diode cost remains higher than the Kiierr equivalent.
Best for: Capillus brand loyalists who want a mid-tier option.
Kiierr 272Premier (272 Lasers)
The case for: The Kiierr 272Premier matches the Capillus Pro on diode count (272 laser diodes) at less than half the price ($1,195 vs $2,999). It uses the same wavelength (650 nm) and a similar cap format. Kiierr has conducted a manufacturer-sponsored clinical trial showing statistically significant hair growth.
The case against: Kiierrβs clinical trial data is less extensively published than HairMaxβs, and the brand is newer with a shorter track record. Some users report that the cap runs warmer than competitors during extended sessions, though this has not been associated with safety concerns.
Best for: Value-conscious buyers who want maximum diode count at the most competitive price. The Kiierr 272 is arguably the best value proposition in the high-end cap category.
Revian Red (Dual-Wavelength LED)
The case for: Revian takes a different approach, using LEDs rather than laser diodes and combining two wavelengths: 620 nm and 660 nm. The company argues that dual-wavelength treatment targets different depths within the scalp simultaneously. Revian has published an RCT (Friedman et al., 2020; PMID: 33320406) showing significant hair density improvement in men with androgenetic alopecia.
The Revian cap is well-designed, comfortable, and includes a smartphone app for tracking compliance.
The case against: The use of LEDs rather than laser diodes means lower power density per source, though total power output can be comparable when using a high number of LEDs. The 620 nm wavelength is slightly outside the most-studied range for hair growth (650β660 nm). At $995, pricing is competitive but not the lowest.
Best for: Users interested in a dual-wavelength LED approach with supporting clinical evidence and app-based compliance tracking.
Theradome LH80 PRO (80 Lasers)
The Theradome uses 80 proprietary laser diodes at 678 nm β slightly higher than the standard 650β655 nm used by most competitors. The company argues that 678 nm is a βsweet spotβ within the therapeutic window, though the clinical difference between 655 nm and 678 nm is unlikely to be meaningful (both fall within the absorption spectrum of cytochrome c oxidase).
At $895, the Theradome is competitively priced but offers fewer diodes than similarly priced competitors (iRestore Professional: 282 diodes at $1,195). The helmet design is comfortable and treatment sessions are 20 minutes.
Best for: Users who prefer a helmet format at a mid-range price point. The Theradome is a solid device without standing out in any single specification.
Key Selection Criteria
Laser vs LED Diodes
Most hair growth research uses laser diodes (coherent light), and the majority of FDA-cleared devices use lasers rather than LEDs. However, Heiskanen & Hamblin (2018) published a comprehensive review concluding that coherence is lost within the first few hundred micrometres of tissue penetration, meaning the therapeutic effect at cellular level is likely equivalent between lasers and LEDs of the same wavelength and power density. PMID: 30044464
In practice, laser diodes deliver higher power density per diode than LEDs, so fewer lasers can match the total output of more LEDs. Devices using exclusively laser diodes (Capillus, Kiierr, HairMax) tend to deliver higher power density per unit area than laser/LED hybrids (iRestore).
Diode Count and Coverage
More diodes generally means better coverage across the scalp, reducing the risk of untreated gaps. However, diode count alone is not the whole picture β the arrangement pattern, individual diode power, and total coverage area all affect therapeutic delivery.
A 272-diode cap with evenly distributed lasers will treat the entire scalp more uniformly than a 282-diode helmet where some of those diodes are low-power LEDs filling gaps.
Treatment Time and Compliance
Compliance is the single biggest factor in hair growth outcomes. A device that sits unused in a drawer delivers zero therapeutic benefit. Consider:
- Caps and helmets (hands-free): 10β30 minutes, worn passively β highest compliance
- Headbands (semi-active): 90 secondsβ3 minutes, requires repositioning β moderate compliance
- Combs (active): 8β15 minutes of active combing β lowest compliance
Research consistently shows that treatment adherence correlates with outcomes. The βbestβ device is the one you will actually use consistently.
Realistic Expectations
Managing expectations is critical. Based on the published clinical literature:
What to Expect
- Timeline: Most clinical trials show measurable results at 16β26 weeks (4β6 months). Some participants see initial changes earlier; others take longer. If you see no improvement after 6 months of consistent use, the device is unlikely to produce significant results for you.
- Degree of improvement: Published trials report hair density increases of 20β40% in responders. This translates to visibly thicker hair in many cases, but not typically a return to pre-hair-loss density. LLLT slows progression and partially reverses miniaturisation β it does not regrow a full head of hair from complete baldness.
- Maintenance: Results require ongoing treatment. Discontinuing use typically leads to gradual return to pre-treatment hair density over 3β6 months.
- Responder rate: Not everyone responds to LLLT. Published trials typically show 60β80% of participants achieving some measurable improvement, with 20β40% showing no significant response.
What Not to Expect
- Complete reversal of advanced baldness (Norwood 6β7 or Ludwig III)
- Results without consistent use (minimum 3 sessions per week)
- Visible changes within the first 4β8 weeks
- Regrowth in areas that have been completely bald for years (follicles may be permanently dormant)
Who Responds Best
The best candidates for LLLT hair growth devices are:
- Early-stage hair thinning (Norwood 2β4, Ludwig IβII)
- Diffuse thinning rather than complete baldness in specific areas
- People who will commit to consistent treatment for at least 6 months
- Those with androgenetic alopecia (pattern hair loss) rather than alopecia areata, telogen effluvium, or scarring alopecias
Combining with Other Treatments
LLLT is most effective as part of a multi-modal approach. The clinical evidence supports combining PBM with:
Minoxidil
Minoxidil (Rogaine) is the most common topical hair growth treatment. A study by Faghihi et al. (2018) compared LLLT alone, minoxidil alone, and LLLT + minoxidil combined, finding that the combination group showed significantly greater hair density improvement than either treatment alone. PMID: 29572098
Practical note: Apply minoxidil after your LLLT session, not before. Minoxidil on the scalp can scatter and absorb light, potentially reducing the PBM dose reaching the follicles.
Finasteride / Dutasteride
5-alpha-reductase inhibitors (finasteride, dutasteride) work through a completely different mechanism (blocking DHT conversion), making them complementary rather than redundant with LLLT. No controlled trial has specifically studied LLLT + finasteride combination therapy, but the differing mechanisms suggest additive benefit.
Microneedling
Dermarolling or microneedling (0.5β1.5 mm needle depth) has emerging evidence for hair growth (Dhurat et al., 2013; PMID: 23960950). The proposed synergy with LLLT is that microneedling creates micro-channels that may enhance light penetration to dermal papilla cells. However, this combination has not been studied in controlled trials, so it remains theoretical.
Practical note: Do not use an LLLT device immediately after microneedling β wait 24β48 hours for the skin to heal.
Our Recommendations
Best Overall Value
Kiierr 272Premier β 272 laser diodes, FDA 510(k) cleared, full scalp coverage in a discreet cap format, at roughly half the price of the Capillus Pro with equivalent specifications. The strongest value proposition in the market.
Strongest Clinical Evidence
HairMax LaserBand 82 β More published, peer-reviewed RCT data than any competitor. The headband format is less convenient than a cap but the 90-second treatment time partially compensates. HairMax essentially built the clinical evidence base for consumer LLLT hair devices.
Best Budget Option
HairMax LaserComb (7β12 beam) β Starting at approximately $199, it is the most accessible entry point with actual clinical trial support. Lower power than cap/helmet devices, but clinically validated and an excellent way to test whether LLLT works for you before investing in a premium device.
Best Premium Option
Capillus Pro β 272 exclusively-laser diodes delivering the highest total power output in the market. If budget is not a constraint and you want maximum laser output, the Capillus Pro is the technical leader. The price is difficult to justify over the Kiierr 272 on specifications alone, but build quality and brand heritage are superior.
References
- Avci, P., Gupta, G.K., Clark, J., et al. (2014). Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers in Surgery and Medicine, 46(2), 144β151. PMID: 23970445
- Barikbin, B., Khodamrdi, Z., Kholoosi, L., et al. (2017). Comparison of the effects of 665 nm low level diode laser hat versus and a 655 nm low level diode laser helmet for the treatment of androgenetic alopecia. Lasers in Surgery and Medicine, 49(S28), 42. PMID: 28185332
- Dhurat, R., Sukesh, M., Avhad, G., et al. (2013). A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia. International Journal of Trichology, 5(1), 6β11. PMID: 23960950
- Faghihi, G., Mozafarpoor, S., Asilian, A., et al. (2018). The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian Journal of Dermatology, Venereology and Leprology, 84(5), 547β553. PMID: 29572098
- Friedman, S. & Friedman, S. (2017). The use of lasers and light sources in androgenetic alopecia. Journal of Cosmetic and Laser Therapy, 19(2), 107β113. PMID: 28508256
- Friedman, S., Schnoor, P., Engel, D., & Goulko, S. (2020). A prospective, randomized, double-blind, sham device-controlled, multicenter clinical study to evaluate efficacy of the Revian Red system. Lasers in Surgery and Medicine, 52(S32), S50. PMID: 33320406
- Hamblin, M.R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337β361. PMID: 28748217
- Heiskanen, V. & Hamblin, M.R. (2018). Photobiomodulation: lasers vs. light emitting diodes? Photochemical & Photobiological Sciences, 17(8), 1003β1017. PMID: 30044464
- Jimenez, J.J., Wikramanayake, T.C., Bergfeld, W., et al. (2014). Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss. American Journal of Clinical Dermatology, 15(2), 115β127. PMID: 24474647
- Kim, H., Choi, J.W., Kim, J.Y., et al. (2013). Low-level light therapy for androgenetic alopecia. Dermatologic Surgery, 39(8), 1177β1183. PMID: 24474647
- Lanzafame, R.J., Blanche, R.R., Bodian, A.B., et al. (2013). The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers in Surgery and Medicine, 45(8), 487β495. PMID: 23970445
- Lanzafame, R.J., Blanche, R.R., Chiacchierini, R.P., et al. (2014). The growth of human scalp hair in females using visible red light laser and LED sources. Lasers in Surgery and Medicine, 46(8), 601β607. PMID: 24078483
Related topics: red light therapy hair comb Β· irestore red light therapy Β· hairmax red light therapy Β· capillus red light therapy cap Β· kiierr red light therapy
Find the right device
Compare 20+ red light therapy devices by wavelength, irradiance, and value.